Diagnostic sensitivity of SILVAMP TB-LAM point-of-care urine assay for extra-pulmonary tuberculosis
Andrew D.Â Kerkhoff,BiancaÂ Sossen,Â CharlotteÂ Schutz,Â Elena IvanovaÂ Reipold,Â AndreÂ Trollip,Â EmmanuelÂ Moreau,Â Samuel G.Â Schumacher,Â RosieÂ Burton,Â AmyÂ Ward,Â Mark P.Â Nicol,Â GraemeÂ Meintjes,Â Claudia M.Â Denkinger,Â TobiasÂ Broger
European Respiratory JournalÂ 2019;Â DOI:Â 10.1183/13993003.01259-2019
Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
This manuscript has recently been accepted for publication in theÂ European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of theÂ ERJÂ online. Please open or download the PDF to view this article.
Conflict of interest: D. Kerkhoff
Conflict of interest: Bianca Sossen
Conflict of interest: Charlotte Schutz
Conflict of interest: Dr. Reipold has nothing to disclose.
Conflict of interest: Andre Trollip
Conflict of interest: Emmanuel Moreau
Conflict of interest: G. Schumacher
Conflict of interest: Rosie Burton
Conflict of interest: Amy Ward
Conflict of interest: P. Nicol
Conflict of interest: Graeme Meintjes
Conflict of interest: Dr. Denkinger reports and CMD is a former employee of FIND. FIND is a non-for-profit foundation, whose mission is to find diagnostic solutions to overcome diseases of poverty in LMICs. It works closely with the private and public sectors and receives funding from some of its industry partners. It has organisational firewalls to protect it against any undue influences in its work or the publication of its findings. All industry partnerships are subject to review by an independent Scientific Advisory Committee or another independent review body, based on due diligence, TTPs and public sector requirements. FIND catalyses product development, leads evaluations, takes positions, and accelerates access to tools identified as serving its mission. It provides indirect support to industry (e.g., access to open specimen banks, a clinical trial platform, technical support, expertise, laboratory capacity strengthening in LMICs, etc.) to facilitate the development and use of products in these areas. FIND also
Conflict of interest: Tobias Broger
This is a PDF-only article. Please click on the PDF link above to read it.
- ReceivedÂ June 24, 2019.
- AcceptedÂ October 18, 2019.
- Copyright Â©ERS 2019